2nd Quarter - Report
NOVAVAX, INC for NOVAVAX, INC
Firm
Client
Income
—
Expenses
$90,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to COVID-19 vaccines Reauthorization of Pandemic and All-Hazards Preparedness Act General discussions related to vaccine injury compensation programs and vaccine strain selection timelines. FY2025 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations process.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY CAPPIO | — |
| DANIELLE FREDERICKS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.